Daniel Wade Rademacher, | |
995 S Clarizz Blvd, Bloomington, IN 47401-5588 | |
(812) 353-3060 | |
Not Available |
Full Name | Daniel Wade Rademacher |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 995 S Clarizz Blvd, Bloomington, Indiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073084612 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | 71008616A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Daniel Wade Rademacher, 995 S Clarizz Blvd, Bloomington, IN 47401-5588 Ph: () - | Daniel Wade Rademacher, 995 S Clarizz Blvd, Bloomington, IN 47401-5588 Ph: (812) 353-3060 |
News Archive
23andMe has launched a project funded by the National Institutes of Health which is aimed at validating 23andMe's highly-scalable platform for pharmacogenomics research. The company received $190,000 in stimulus funding from the American Recovery and Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide Association Studies of Drug Response" from NIH's National Human Genome Research Institute.
A new preprint research paper posted to the medRxiv* server found changes to the lung microbiome during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection influence COVID-19 disease severity.
Brazil is expanding its national HIV/AIDS treatment program to include about 35,000 additional people, the Associated Press/Seattle Times reports. "Ronaldo Hallal of the health ministry's Sexually Transmitted Disease Department said people with 500 or fewer CD4 cells per cubic millimeter will receive antiretroviral HIV treatment," increasing the cutoff from 350 or less CD4 cells per cubic millimeter prior to the expansion, the news service writes.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced that it has granted PROCAPS S.A. exclusive rights to market and sell DAVANATĀ® to treat cancer in Colombia, South America. Phase ll clinical trial results for late-stage colorectal cancer patients demonstrate that when DAVANATĀ® is co-administered with the chemotherapy drug 5-FU, survival increased by 46% over the best standard of care and reduced serious adverse events associated with chemotherapy.
Testosterone is an important androgen hormone in the health and well-being of men and women. Testosterone levels are associated with sexual development, libido, protection against osteoporosis, and cardiovascular health. In men, insufficient testosterone levels (hypogonadism) have been linked to obesity and low libido.
› Verified 5 days ago
Ruana Cronin, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-355-3299 Fax: 812-355-3290 | |
Beverly J Shamloo, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1520 S Liberty Dr, Bloomington, IN 47403 Phone: 812-676-4500 | |
Pamela Ann Maclaughlin, DNP, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 550 S Adams St, Bloomington, IN 47403 Phone: 812-333-6324 Fax: 812-331-6700 | |
Nichole Hickman, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 350 S Landmark Ave, Bloomington, IN 47403 Phone: 812-335-2434 Fax: 812-335-7604 | |
Robert G Pursell, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-353-9515 | |
Emilee J Mcglone, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-330-3688 Fax: 812-355-3270 | |
Erin Elizabeth Barnett, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 550 S Landmark Ave, Bloomington, IN 47403 Phone: 812-355-6900 |